Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 111 — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements · § 111.140

§ 111.140. Under this subpart F, what records must you make and keep?

307 words·~1 min read·/us/cfr/t21/s§ 111.140·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)You must make and keep the records required under this subpart F in accordance with subpart P of this part.
(b)You must make and keep the following records:
(1)Written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision and written procedures for approving or rejecting any reprocessing;
(2)Written documentation, at the time of performance, that quality control personnel performed the review, approval, or rejection requirements by recording the following:
(i)Date that the review, approval, or rejection was performed; and
(ii)Signature of the person performing the review, approval, or rejection; and
(3)Documentation of any material review and disposition decision and followup. Such documentation must be included in the appropriate batch production record and must include:
(i)Identification of the specific deviation or the unanticipated occurrence;
(ii)Description of your investigation into the cause of the deviation from the specification or the unanticipated occurrence;
(iii)Evaluation of whether or not the deviation or unanticipated occurrence has resulted in or could lead to a failure to ensure the quality of the dietary supplement or a failure to package and label the dietary supplement as specified in the master manufacturing record;
(iv)Identification of the action(s) taken to correct, and prevent a recurrence of, the deviation or the unanticipated occurrence;
(v)Explanation of what you did with the component, dietary supplement, packaging, or label;
(vi)A scientifically valid reason for any reprocessing of a dietary supplement that is rejected or any treatment or in-process adjustment of a component that is rejected; and
(vii)The signature of the individual(s) designated to perform the quality control operation, who conducted the material review and made the disposition decision, and of each qualified individual who provides information relevant to that material review and disposition decision.
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.